|
Group 1
BMI>30
Placebo
(2100 Kcal/day diet)
|
Group 2
BMI>30
CORE
(no dietary restriction)
|
Group 3
BMI>30
CORE
(2100 Kcal/day diet)
|
Group 4
BMI>30
CQR-300
(2100 Kcal/day diet)
|
Group 5
BMI 24–29.9
CORE
(no dietary restriction)
|
---|
Time (weeks)
|
T = 0
|
T = 6
|
T = 0
|
T = 8
|
T = 0
|
T = 8
|
T = 0
|
T = 6
|
T = 0
|
T = 8
|
Total Cholesterol (mg/dL)
|
136.3 ± 9.0
|
138.3 ± 11.1
|
159.1 ± 14.6
|
116.2 ± 9.7*
|
171.0 ± 15.9
|
126.5 ± 7.9 *†
|
138.3 ± 13.8
|
113.4 ± 4.5*
|
152.6 ± 8.8
|
123.0 ± 4.7*
|
LDL-cholesterol (mg/dL)
|
88.4 ± 5.9
|
88.2 ± 5.9
|
99.8 ± 6.5
|
81.4 ± 1.7
|
116.6 ± 5.4
|
78.8 ± 3.3
|
92.7 ± 7.0
|
65.8 ± 3.4
|
101.6 ± 1.9
|
74.8 ± 0.9
|
HDL-cholesterol (mg/dL)
|
27.3 ± 2.2
|
25.8 ± 3.1
|
36.6 ± 4.7
|
55.1 ± 6.4*
|
38.6 ± 10.5
|
55.2 ± 8.6*†
|
25.6 ± 4.8
|
31.0 ± 3.9
|
44.4 ± 7.7
|
52.0 ± 8.1
|
Triacylglycerol (mg/dL)
|
93.6 ± 4.8
|
90.5 ± 10.4
|
156.0 ± 16.8
|
95.6 ± 8.1
|
144.9 ± 43.3
|
104.3 ± 26.2*†
|
93.8 ± 9.7
|
73.4 ± 6.0***
|
117.4 ± 9.8
|
99.8 ± 11.2
|
Fasting Blood glucose (mg/dL)
|
93.6 ± 7.2
|
89.4 ± 10.1
|
101.3 ± 8.6
|
87.7 ± 10.0
|
102.4 ± 1.8
|
85.9 ± 5.2
|
91.8 ± 6.9
|
78.4 ± 11.2
|
93.3 ± 10.2
|
82.7 ± 7.2
|
- Values are means ± SE, comparing starting point to end point, significant differences were at *p < 0.05, **p < 0.01 and ***p < 0.001 for the same treatment.